Alectinib approved by FDA for ALK-positive lung cancer Alectinib, a new drug for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer, has been approved by the US Food and Drug Administration.…
FDA approves uridine triacetate as chemotherapy overdose rescue A new rescue treatment for patients accidentally given an overdose of chemotherapy has been approved by the US Food and Drug Administration.…
Smoking cessation services will not be bound by e-cigarette advertising restrictions Pharmacists running smoking cessation services in England, Wales and Northern Ireland will still be able to promote the option of e-cigarettes under new European advertising rules coming into force in 2016.…
World’s first vaccine against the Dengue virus approved in Mexico The first vaccine in the world to prevent the dengue virus has been approved for use in Mexico, the country’s drugs regulator has announced.…
FDA approves treatment for inherited bleeding disorder Recombinant von Willebrand factor, a treatment for an inherited bleeding disorder, has been approved by the US Food and Drug Administration.…
New heart failure drug extends survival by up to two years A re-analysis of trial data reveals that the highly effective new drug sacubitril-valsartan could extend life by two years compared with enalapril for cardiovascular patients.…
FDA approves new multiple myeloma drug elotuzumab A new immune-stimulating treatment for multiple myeloma has been approved by the US Food and Drug Administration.…
FDA approves necitumumab for non-small cell lung cancer Necitumumab (Portrazza) has been approved by the US drugs safety watchdog as a new combination therapy for patients with advanced squamous non-small cell lung cancer who have not received other treatment for their advanced disease.…
FDA approves first oral proteasome inhibitor for multiple myeloma A new combination therapy for patients with multiple myeloma whose previous treatment has failed has been approved by the US Food and Drug Administration.…
First in class narcolepsy medicine recommended for approval in Europe The first drug of its kind to treat patients with the rare but long-term sleep disorder narcolepsy is being recommended for use across the European Union.…
